ARS Pharmaceuticals, Inc. ($SPRY)
Filing Information
| Accession Number | 0001951287-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
75,000
Total Value
$287,500.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 25,000 | $1.50 | $37,500.00 | 37,176 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Jun 12, 2026 | Sale | 25,000 | $10.00 | $250,000.00 | 12,176 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 519,588 | Direct | โ | View Details |